Log in to save to my catalogue

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2597064

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

About this item

Full title

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

Publisher

New York: Nature Publishing Group US

Journal title

Nature neuroscience, 2008-11, Vol.11 (11), p.1311-1318

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The contribution of fatty acids to Alzheimer's disease pathogenesis is unclear. The authors identify an increase in arachadonic acid and its metabolites in a mouse model for Alzheimer's disease and show that amyloid-beta (Aβ) affects phosphorylation of an isoform of phospholipase A
2
(GIVA-PLA
2
). Inhibiting activation of GIVA-PLA
2...

Alternative Titles

Full title

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2597064

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2597064

Other Identifiers

ISSN

1097-6256

E-ISSN

1546-1726

DOI

10.1038/nn.2213

How to access this item